Huawei Unveils Advanced Chip Design Approach Intensifying Competition with Nvidia and Apple US AI Integration in Asia Gains Urgency Following TrumpXi Summit Microsoft Faces Headwinds Amid SaaSmaggedon Market SellOff Strive Asset Management Increases Bitcoin Holdings to 16500 Tokens BP Chairman Removed Amid Allegations of Bullying and Overbearing Behaviour Singapore April Inflation Below Expectations at 18 Core GDP Growth Revised Upward KMPR Q1 2026 Earnings EPS Falls Short of Estimates as Underwriting Challenges Persist VLYPP Q1 2026 Earnings Preferred EPS Beats Estimates Stock Declines Slightly ASAN Q1 2026 Earnings EPS Beat Surprises as Asana Reports Strong Profitability Aon plc AON Q1 2026 Earnings EPS Beats Estimates as Stock Edges Lower VLN Q1 2026 Earnings NarrowerThanExpected Loss Drives Share Rally GLMD Q4 2025 Earnings WiderThanExpected Loss as Galmed Continues Clinical Development NPFD Edges Higher as Investors Steady Holdings Nuveen Variable Rate Preferred Income Fund NPFD Analysis Kustom Entertainment Inc KUST Gains 359 as Shares Approach Resistance at 333 Expeditors International EXPD Rises 19 as Logistics Demand Remains Steady at 16149 Barings Corporate Investors MCI Gains 253 as Shares Approach Key Resistance Level Aimei Health Technology AFJKU Faces Sharp Decline Support Levels in Focus Barnes Noble CEO James Daunt Clarifies Stance on AIWritten Books Emphasizes Publisher Responsibility GABC Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Highview Merger Corp Warrants HVMCW Trading Flat at 030 as Support Holds Steady Osisko Development Corp ODV Declines Approaching Critical Support Level FTI Consulting FCN Edges Higher Near Resistance as Consolidation Pattern Emerges Rand Capital RAND Sees a 15 Upswing as Shares Approach Key Resistance Iron Horse Acquisitions II Corp Units IRHOU Holds Steady at 1017 Consolidating Near Key Levels Schrodinger Inc SDGR Holds Steady Near Support as Shares Trade Nearly Flat SHF Holdings Inc SHFS Falls Toward Support as Digital Banking Headwinds Persist XTL Biopharmaceuticals XTLB Pulls Back to 247 Pressing Near Support